WHO rules involve manufacturers to carry out a ongoing threat management method for sterility test isolators, which includes normal hazard assessments and the development of risk-dependent Regulate tactics. The danger management approach starts with a thorough Evaluation of probable failure modes and their prospective impacts on sterility as